Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
TNFRⅡ fusion protein(biosimilar) | Fusion/Recombination protein | Immunological disease | Rheumatoid Arthritis,Psoriasis,Ankylosing Spondylitis | NDA/BLA | Global (except China) |
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
TN2-M82E3 | Mouse | Biotinylated Mouse TNFR2 / CD120b / TNFRSF1B Protein, His,Avitag™ (MALS verified) |
|
||
TN2-H82F3 | Human | Biotinylated Human TNFR2 / CD120b / TNFRSF1B Protein, Fc,Avitag™ (MALS verified) |
|
||
TN2-M5254 | Mouse | Mouse TNFR2 / CD120b / TNFRSF1B Protein, Fc Tag (MALS verified) |
|
||
TN2-H5253 | Human | Human TNFR2 / CD120b / TNFRSF1B Protein, Fc Tag (MALS verified) |
|
||
TN2-M52H8 | Mouse | Mouse TNFR2 / CD120b / TNFRSF1B Protein, His Tag |
|
||
TN2-C52H7 | Cynomolgus / Rhesus macaque | Cynomolgus / Rhesus macaque TNFR2 / CD120b / TNFRSF1B Protein, His Tag |
|
||
TN2-H82E3 | Human | Biotinylated Human TNFR2 / CD120b / TNFRSF1B Protein, His,Avitag™ (MALS verified) |
|
||
TN2-H5227 | Human | Human TNFR2 / CD120b / TNFRSF1B Protein, His Tag (MALS verified) |
|
Immobilized Human TNF-alpha Protein, His Tag (Cat. No. TNA-H5228) at 5 μg/mL (100 μL/well) can bind Biotinylated Human TNFR2 Protein, Fc,Avitag (Cat. No. TN2-H82F3) with a linear range of 0.01-0.313 μg/mL (QC tested).
The purity of Biotinylated Mouse TNFR2 Protein, His,Avitag (Cat. No. TN2-M82E3) is more than 90% and the molecular weight of this protein is around 40-55 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Recombinant human type II tumor necrosis factor receptor-antibody fusion protein(Hisun Biological) | Approved | Mainland China | Psoriasis; Arthritis, Rheumatoid; Spondylitis, Ankylosing | Hisun Biopharmaceutical Co Ltd | 2015-04-09 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis | Details | |||
Recombinant human type II tumor necrosis factor receptor-antibody fusion protein(Hisun Biological) | Approved | Mainland China | Psoriasis; Arthritis, Rheumatoid; Spondylitis, Ankylosing | Hisun Biopharmaceutical Co Ltd | 2015-04-09 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
LBL-019 | LBL-019 | Phase 2 Clinical | Nanjing Leads Biolabs Co Ltd | Neoplasms | Details |
BI-1910 | BI-1910 | Phase 2 Clinical | Bioinvent International Ab | Solid tumours; Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung | Details |
BITR-2101 | BITR-2101; BIR-2101; BITT2101; BITT-2101 | Phase 1 Clinical | Infections; Neoplasms; Lymphoma, Non-Hodgkin | Details | |
NBL-020 | Phase 1 Clinical | Shanghai Xinshi Biological Medicine Co Ltd | Solid tumours; Neoplasms | Details | |
SIM1811-03 | SIM1811-03; SIM0235; SIM-235 | Phase 1 Clinical | Jiangsu Simcere Pharmaceutical Co Ltd | Solid tumours; Neoplasms; Lymphoma, T-Cell, Cutaneous | Details |
HFB-2003(HiFiBiO Therapeutics) | HFB-200301; HFB-2003 | Phase 1 Clinical | HiFiBiO Therapeutics | Skin Melanoma; Solid tumours; Carcinoma, Renal Cell; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Mesothelioma; Sarcoma; Testicular Neoplasms; Germinoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Neoplasm Metastasis | Details |
LBL-019 | LBL-019 | Phase 2 Clinical | Nanjing Leads Biolabs Co Ltd | Neoplasms | Details |
BI-1910 | BI-1910 | Phase 2 Clinical | Bioinvent International Ab | Solid tumours; Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung | Details |
BITR-2101 | BITR-2101; BIR-2101; BITT2101; BITT-2101 | Phase 1 Clinical | Infections; Neoplasms; Lymphoma, Non-Hodgkin | Details | |
NBL-020 | Phase 1 Clinical | Shanghai Xinshi Biological Medicine Co Ltd | Solid tumours; Neoplasms | Details | |
SIM1811-03 | SIM1811-03; SIM0235; SIM-235 | Phase 1 Clinical | Jiangsu Simcere Pharmaceutical Co Ltd | Solid tumours; Neoplasms; Lymphoma, T-Cell, Cutaneous | Details |
HFB-2003(HiFiBiO Therapeutics) | HFB-200301; HFB-2003 | Phase 1 Clinical | HiFiBiO Therapeutics | Skin Melanoma; Solid tumours; Carcinoma, Renal Cell; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Mesothelioma; Sarcoma; Testicular Neoplasms; Germinoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Neoplasm Metastasis | Details |
This web search service is supported by Google Inc.